[go: up one dir, main page]

ES2161759T3 - Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion. - Google Patents

Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion.

Info

Publication number
ES2161759T3
ES2161759T3 ES94909071T ES94909071T ES2161759T3 ES 2161759 T3 ES2161759 T3 ES 2161759T3 ES 94909071 T ES94909071 T ES 94909071T ES 94909071 T ES94909071 T ES 94909071T ES 2161759 T3 ES2161759 T3 ES 2161759T3
Authority
ES
Spain
Prior art keywords
pct
projects
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94909071T
Other languages
English (en)
Inventor
Karl-Heinz Budt
Bernd Stowasser
Anuschirwan Peyman
Jochen Knolle
Irvin Winkler
Hans-Gerd Berscheid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2161759T3 publication Critical patent/ES2161759T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5304—Acyclic saturated phosphine oxides or thioxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A MEDICAMENTOS DE INHIBIDORES DE ENZIMA DONDE AL MENOS UN GRUPO OH HA SIDO CONVERTIDO EN EL INHIBIDOR DE ENZIMA EN UN DERIVADO POR MEDIO DE UNA AGRUPACION DE LA FORMULA (III HASTA V) EN DONDE LOS GRUPOS R{SUP,11} HASTA R{SUP,25} Y S,L,M,O,Q Y R SE DEFINEN COMO EN LA DESCRIPCION. TALES MEDICAMENTOS EXHIBEN UNA SOLUBILIDAD MEJORA EN AGUA Y CARACTERISTICAS FARMACOCINETICAS MEJORADAS.
ES94909071T 1993-03-13 1994-02-25 Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion. Expired - Lifetime ES2161759T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4308096A DE4308096A1 (de) 1993-03-13 1993-03-13 Prodrug-Derivate von Enzyminhibitoren mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2161759T3 true ES2161759T3 (es) 2001-12-16

Family

ID=6482773

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94909071T Expired - Lifetime ES2161759T3 (es) 1993-03-13 1994-02-25 Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion.

Country Status (10)

Country Link
US (1) US5804559A (es)
EP (1) EP0688314B1 (es)
JP (1) JPH08507770A (es)
AT (1) ATE206393T1 (es)
AU (1) AU6207094A (es)
DE (2) DE4308096A1 (es)
DK (1) DK0688314T3 (es)
ES (1) ES2161759T3 (es)
PT (1) PT688314E (es)
WO (1) WO1994021604A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753652A (en) * 1991-07-03 1998-05-19 Novartis Corporation Antiretroviral hydrazine derivatives
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
EP1302468B1 (en) * 1992-12-29 2008-12-17 Abbott Laboratories Processes and intermediates for manufacturing retroviral protease inhibiting compounds
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
AU2012199A (en) * 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
AU2004233898B2 (en) 2003-04-25 2010-12-23 Gilead Sciences, Inc. Antiviral phosphonate analogs
EP1656387A2 (en) 2003-07-30 2006-05-17 Gilead Sciences, Inc. Nucleobase phosphonate analogs for antiviral treatment
ES2363160T3 (es) 2004-07-27 2011-07-22 Gilead Sciences, Inc. Conjugados de fosfonato nucelosidico como agentes anti-vih.
BRPI0713961A2 (pt) 2006-07-07 2012-11-27 Gilead Sciences Inc compostos fosfinatos antivirais
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
JP5620376B2 (ja) 2008-07-08 2014-11-05 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖ阻害剤化合物の塩
HK1205697A1 (zh) * 2012-04-25 2015-12-24 Ascendis Pharma A/S 含有羟基的药物的前药
US9765022B2 (en) * 2013-02-28 2017-09-19 Tufts University Disulfide compounds for delivery of pharmaceutical agents
ES2892402T3 (es) 2017-08-01 2022-02-04 Gilead Sciences Inc Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428849A3 (en) * 1989-09-28 1991-07-31 Hoechst Aktiengesellschaft Retroviral protease inhibitors
AU1677092A (en) * 1991-03-20 1992-10-21 Vertex Pharmaceuticals Incorporated Tetrahydroxyalkane derivatives as inhibitors of hiv aspartyl protease

Also Published As

Publication number Publication date
AU6207094A (en) 1994-10-11
ATE206393T1 (de) 2001-10-15
DE59409894D1 (de) 2001-11-08
EP0688314B1 (de) 2001-10-04
PT688314E (pt) 2002-03-28
EP0688314A1 (de) 1995-12-27
JPH08507770A (ja) 1996-08-20
DE4308096A1 (de) 1994-09-15
WO1994021604A1 (de) 1994-09-29
DK0688314T3 (da) 2001-12-10
US5804559A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
ES2161759T3 (es) Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion.
TW283716B (es)
BR9408323A (pt) Derivados de rapamicina
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
DE59510246D1 (de) Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
AU7495096A (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
AU2670195A (en) Use of gel formulations as dressing compositions
IL122737A0 (en) Salts of amidine derivative and cyclooxygenase inhibitors their preparation and pharmaceutical compositions containing them
DK0751941T3 (da) Kemiske mellemprodukter, som kan anvendes i landbruget
DE59308187D1 (en) Substituierte ortho-ethenylphenylessigsäurederivate
ES2132384T3 (es) Heteroaril alquil tiopiridina sustituida para la lucha contra bacterias helicobacter.
ES2167362T3 (es) Sales de piridinio y su utilizacion para combatir a bacterias helicobacter.
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
SE9402241D0 (sv) Inhibitor
ATE184305T1 (de) Monoazopigmente
DK0731801T3 (da) Substituerede aminoaylkylaminopyridiner
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
ES2146581T3 (es) 2,4- y 2,5-bis-tetrazolilpiridinas, procedimiento para su preparacion, asi como su empleo como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 688314

Country of ref document: ES